Related references
Note: Only part of the references are listed.A unified catalog of 204,938 reference genomes from the human gut microbiome
Alexandre Almeida et al.
NATURE BIOTECHNOLOGY (2021)
Gut microbiota in human metabolic health and disease
Yong Fan et al.
NATURE REVIEWS MICROBIOLOGY (2021)
The gut microbiota-brain axis in behaviour and brain disorders
Livia H. Morais et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Gut microbiota-associated trimethylamine N-oxide and increased cardiometabolic risk in adults: a systematic review and dose-response meta-analysis
Mahdieh Abbasalizad Farhangi et al.
NUTRITION REVIEWS (2021)
Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model
Min-Soo Kim et al.
GUT (2020)
Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide
Yingqian Zhu et al.
APMIS (2020)
Implications of the Gut Microbiome in Parkinson's Disease
Mohamed Elfil et al.
MOVEMENT DISORDERS (2020)
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
Aonghus Lavelle et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide
Basak Donertas Ayaz et al.
PHARMACOLOGICAL RESEARCH (2020)
Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism
Su-Ling Zeng et al.
SCIENCE ADVANCES (2020)
The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases
Estefania Sanchez-Rodriguez et al.
NUTRIENTS (2020)
A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors
Ina Nemet et al.
CELL (2020)
Intestinal fatty acid-binding protein mediates atherosclerotic progress through increasing intestinal inflammation and permeability
Lulu Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Implication of the gut microbiome composition of type 2 diabetic patients from northern China
Qian Li et al.
SCIENTIFIC REPORTS (2020)
Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential
Zubaidah Hasain et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms
He Zhou et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
Paula Iruzubieta et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study
Hao Wu et al.
CELL METABOLISM (2020)
Gut dysbiosis contributes to amyloid pathology, associated with C/EBPβ/AEP signaling activation in Alzheimer's disease mouse model
Chun Chen et al.
SCIENCE ADVANCES (2020)
Microbiota-derived metabolite promotes HDAC3 activity in the gut
Shu-en Wu et al.
NATURE (2020)
The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic
Eliran Kadosh et al.
NATURE (2020)
Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review
He Zhou et al.
DISEASE MARKERS (2020)
Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta-analysis
Toon J. I. De Munck et al.
LIVER INTERNATIONAL (2020)
Microbiota-modulated CART+ enteric neurons autonomously regulate blood glucose
Paul A. Muller et al.
SCIENCE (2020)
Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome
Oren Rom et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A
Young-Chae Kim et al.
NATURE COMMUNICATIONS (2020)
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage
Aurelie Fluckiger et al.
SCIENCE (2020)
Prevention of Gestational Diabetes Mellitus (GDM) and Probiotics: Mechanism of Action: A Review
Aziz Homayouni et al.
CURRENT DIABETES REVIEWS (2020)
Host-microbiota interactions in inflammatory bowel disease
Roberta Caruso et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease
Huikuan Chu et al.
GUT (2019)
Potential Influences of Gut Microbiota on the Formation of Intracranial Aneurysm
Fumiaki Shikata et al.
HYPERTENSION (2019)
Revisit gut microbiota and its impact on human health and disease
Rui-xue Ding et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2019)
Effect of ethanol on lipid metabolism
Min You et al.
JOURNAL OF HEPATOLOGY (2019)
Critical Role of the Interaction Gut Microbiota - Sympathetic Nervous System in the Regulation of Blood Pressure
Marta Toral et al.
FRONTIERS IN PHYSIOLOGY (2019)
Temporally Distinct Functions of the Cytokines IL-12 and IL-23 Drive Chronic Colon Inflammation in Response to Intestinal Barrier Impairment
Christina Eftychi et al.
IMMUNITY (2019)
The gut microbiota and colon cancer
Wendy S. Garrett
SCIENCE (2019)
Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China
Chunxiao Li et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives
Natalia Vallianou et al.
CURRENT OBESITY REPORTS (2019)
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota
Binyin Li et al.
ALZHEIMERS & DEMENTIA (2019)
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression
Xinyi Wang et al.
CELL RESEARCH (2019)
Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity
Xiaohang Long et al.
NATURE MICROBIOLOGY (2019)
The Genetic Contribution to Type 1 Diabetes
Marina Bakay et al.
CURRENT DIABETES REPORTS (2019)
Microbial Metabolites Determine Host Health and the Status of Some Diseases
Panida Sittipo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Effects of a High-Protein/Moderate-Carbohydrate Diet on Appetite, Gut Peptides, and Endocannabinoids-A Preview Study
Lea Tischmann et al.
NUTRIENTS (2019)
Gut microbial metabolites in obesity, NAFLD and T2DM
Emanuel E. Canfora et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Trimethylamine N-Oxide, Circulating Endothelial Progenitor Cells, and Endothelial Function in Patients with Stable Angina
Ruey-Hsing Chou et al.
SCIENTIFIC REPORTS (2019)
The Nasal and Gut Microbiome in Parkinson's Disease and Idiopathic Rapid Eye Movement Sleep Behavior Disorder
Anna Heintz-Buschart et al.
MOVEMENT DISORDERS (2018)
Alteration of the fecal microbiota in Chinese patients with Parkinson's disease
Yiwei Qian et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies
Chao Peng et al.
NATURE (2018)
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Lesley Hoyles et al.
NATURE MEDICINE (2018)
Alzheimer's disease and gut microbiota modifications: The long way between preclinical studies and clinical evidence
Cesare Mancuso et al.
PHARMACOLOGICAL RESEARCH (2018)
miR-192 is upregulated in T1DM, regulates pancreatic -cell development and inhibits insulin secretion through suppressing GLP-1 expression
Wen Pan et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases
Sara Gerhardt et al.
NUTRIENTS (2018)
Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Hannah E. Da Silva et al.
SCIENTIFIC REPORTS (2018)
P2467Gut microbiota-dependent TMAO and risk of cardiovascular events in patients with stroke: relation to pro-inflammatory monocytes
A Haghikia et al.
EUROPEAN HEART JOURNAL (2018)
Gut microbiota in patients with Parkinson's disease in southern China
Aiqun Lin et al.
PARKINSONISM & RELATED DISORDERS (2018)
SCFAs strongly stimulate PYY production in human enteroendocrine cells
P. Larraufie et al.
SCIENTIFIC REPORTS (2018)
Gut microbiota is associated with obesity and cardiometabolic disease in a population in the midst of Westernization
Jacobo de la Cuesta-Zuluaga et al.
SCIENTIFIC REPORTS (2018)
Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential
Sarah M. Skye et al.
CIRCULATION RESEARCH (2018)
Increase in clinically recorded type 2 diabetes after colectomy
Anders B. Jensen et al.
ELIFE (2018)
Role of gut microbiota in atherosclerosis
Annika Lindskog Jonsson et al.
NATURE REVIEWS CARDIOLOGY (2017)
Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors
Xinmin S. Li et al.
EUROPEAN HEART JOURNAL (2017)
Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice
Sunny H. Wong et al.
GASTROENTEROLOGY (2017)
Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice
Ho Tsoi et al.
GASTROENTEROLOGY (2017)
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants
Bi Zhou et al.
LANCET (2017)
Parkinson's Disease and Parkinson's Disease Medications Have Distinct Signatures of the Gut Microbiome
Erin M. Hill-Burns et al.
MOVEMENT DISORDERS (2017)
Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention
Ruixin Liu et al.
NATURE MEDICINE (2017)
The gut microbiome in atherosclerotic cardiovascular disease
Zhuye Jie et al.
NATURE COMMUNICATIONS (2017)
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients
J. R. Bedarf et al.
GENOME MEDICINE (2017)
Alterations of the Gut Microbiome in Hypertension
Qiulong Yan et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Connections between human gut microbiome and gestational diabetes mellitus
Ya-Shu Kuang et al.
GIGASCIENCE (2017)
Gut microbiota dysbiosis contributes to the development of hypertension
Jing Li et al.
MICROBIOME (2017)
A proliferative probiotic Bifidobacterium strain in the gut ameliorates progression of metabolic disorders via microbiota modulation and acetate elevation
Ryo Aoki et al.
SCIENTIFIC REPORTS (2017)
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
T. Harach et al.
SCIENTIFIC REPORTS (2017)
Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1ΔE9 murine model of Alzheimer's disease
Myles R. Minter et al.
SCIENTIFIC REPORTS (2017)
Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease
Yodai Kobayashi et al.
SCIENTIFIC REPORTS (2017)
Gut microbiota in Parkinson disease in a northern German cohort
Franziska Hopfner et al.
BRAIN RESEARCH (2017)
Butyrate Regulates Liver Mitochondrial Function, Efficiency, and Dynamics in Insulin-Resistant Obese Mice
Maria Pina Mollica et al.
DIABETES (2017)
Obstructive Sleep Apnea-Induced Hypertension: Role of the Gut Microbiota
David J. Durgan
CURRENT HYPERTENSION REPORTS (2017)
Antihypertensive Effects of Probiotics
Inaki Robles-Vera et al.
CURRENT HYPERTENSION REPORTS (2017)
Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress
Aadil Bharwani et al.
BMC MEDICINE (2017)
Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence
Monika Schaubeck et al.
GUT (2016)
Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice
Kirsty Brown et al.
ISME JOURNAL (2016)
Neuro-Immune Interactions at Barrier Surfaces
Henrique Veiga-Fernandes et al.
CELL (2016)
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease
Timothy R. Sampson et al.
CELL (2016)
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Weifei Zhu et al.
CELL (2016)
Microbiota-Produced Succinate Improves Glucose Homeostasis via Intestinal Gluconeogenesis
Filipe De Vadder et al.
CELL METABOLISM (2016)
Persistent microbiome alterations modulate the rate of post-dieting weight regain
Christoph A. Thaiss et al.
NATURE (2016)
Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System
B. V. Nagpure et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Gut Microbiota Promote Angiotensin II-Induced Arterial Hypertension and Vascular Dysfunction
Susanne H. Karbach et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
Jessica M. Yano et al.
CELL (2015)
Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function
Caleb J. Kelly et al.
CELL HOST & MICROBE (2015)
Gut Dysbiosis Is Linked to Hypertension
Tao Yang et al.
HYPERTENSION (2015)
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition
Christopher J. L. Murray et al.
LANCET (2015)
Microbiota and host determinants of behavioural phenotype in maternally separated mice
G. De Palma et al.
NATURE COMMUNICATIONS (2015)
Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome
Laurence Macia et al.
NATURE COMMUNICATIONS (2015)
In silico analyses of metagenomes from human atherosclerotic plaque samples
Suparna Mitra et al.
MICROBIOME (2015)
Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases
Guoliang Meng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Gut Microbiota Are Related to Parkinson's Disease and Clinical Phenotype
Filip Scheperjans et al.
MOVEMENT DISORDERS (2015)
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
Maitreyi Raman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
The interplay between the intestinal microbiota and the brain
Stephen M. Collins et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK
Jun Xu et al.
JOURNAL OF HEPATOLOGY (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
The H1 Haplotype of the Tau Gene (MAPT) is Associated with Mild Cognitive Impairment
Emilio Di Maria et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Molecular Pathology of Lewy Body Diseases
Katrin Beyer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2009)
The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice
Peter J. Turnbaugh et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
An obesity-associated gut microbiome with increased capacity for energy harvest
Peter J. Turnbaugh et al.
NATURE (2006)
Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis
EV Kozarov et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Share Paper
